This analysis evaluates sketching techniques on spatial transcriptomics data, suggesting spatially aware methods enhance accuracy.
High-throughput spatial transcriptomics (ST) now profiles hundreds of thousands of cells or locations per section, creating computational bottlenecks for routine analysis. Sketching, or intelligent sub-sampling, addresses scale by selecting small, representative subsets. While used in scRNA-seq, most sketching methods optimize coverage in expression space alone and ignore physical location, risking spatial bias. We systematically benchmark uniform sampling, leverage-score sampling, Geosketch (minimax/Hausdorff), and scSampler (maximin) across multiple real ST datasets (mouse ovary, MERFISH brain, human breast cancer, lung) and simulations, using three input representations: PCA embeddings, spatial coordinates, and spatially smoothed embeddings. We show that expression-only designs capture global transcriptomic heterogeneity but distort tissue architecture by over-sampling high-variability regions and under-sampling homogeneous areas. Coordinate-only sampling restores tissue coverage but misses transcriptional extremes. A simple spatially aware extension, computing leverage scores from a randomized SVD basis smoothed by a spatial weights matrix, strikes a favorable balance, recovering rare cell states while maintaining uniform tissue coverage and avoiding edge effects. Across robust Hausdorff distances, clustering stability (ARI), PCA loading drift, and local cell-type MSE, spatially smoothed leverage scores match or outperform alternatives. These results motivate joint spatial-transcriptomic sketching objectives to enable fast, unbiased analyses of increasingly large ST datasets.
No takes yet. Share an insight, caveat, or question.
Gingerich et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: